Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Autolus Therapeutics (AUTL) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for Autolus Therapeutics (AUTL) over the last 2 years, with Q3 2025 value amounting to $28.6 million.

  • Autolus Therapeutics' Cost of Revenue changed N/A to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.4 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Autolus Therapeutics reported Cost of Revenue of $28.6 million as of Q3 2025.
  • In the past 5 years, Autolus Therapeutics' Cost of Revenue ranged from a high of $28.6 million in Q3 2025 and a low of $11.4 million during Q4 2024